Schrumpf E - Search Results

1

Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.

Melum E, Karlsen TH, Schrumpf E, Bergquist A, Thorsby E, Boberg KM, Lie BA. Melum E, et al. Among authors: schrumpf e. Hepatology. 2008 Jan;47(1):90-6. doi: 10.1002/hep.21964. Hepatology. 2008. PMID: 18023027

2

Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis.

Boberg KM, Rocca G, Egeland T, Bergquist A, Broomé U, Caballeria L, Chapman R, Hultcrantz R, Mitchell S, Pares A, Rosina F, Schrumpf E. Boberg KM, et al. Among authors: schrumpf e. Hepatology. 2002 Mar;35(3):652-7. doi: 10.1053/jhep.2002.31872. Hepatology. 2002. PMID: 11870380

3

Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation.

Boberg KM, Jebsen P, Clausen OP, Aabakken L, Brekke I, Schrumpf E. Boberg KM, et al. Among authors: schrumpf e. J Hepatol. 2003 Sep;39(3):453. doi: 10.1016/s0168-8278(03)00326-x. J Hepatol. 2003. PMID: 12927935 No abstract available.

4

Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients.

Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM; IBSEN Study Group. Wiencke K, et al. Among authors: schrumpf e. J Hepatol. 2004 Aug;41(2):209-14. doi: 10.1016/j.jhep.2004.04.024. J Hepatol. 2004. PMID: 15288468

5

Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis.

Bowlus CL, Karlsen TH, Broomé U, Thorsby E, Vatn M, Schrumpf E, Lie BA, Boberg KM. Bowlus CL, et al. Among authors: schrumpf e. J Hepatol. 2006 Nov;45(5):704-10. doi: 10.1016/j.jhep.2006.03.012. Epub 2006 Apr 25. J Hepatol. 2006. PMID: 16750586

6

Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.

Boberg KM, Jebsen P, Clausen OP, Foss A, Aabakken L, Schrumpf E. Boberg KM, et al. Among authors: schrumpf e. J Hepatol. 2006 Oct;45(4):568-74. doi: 10.1016/j.jhep.2006.05.010. Epub 2006 Jun 21. J Hepatol. 2006. PMID: 16879890 Clinical Trial.

7

Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis.

Karlsen TH, Lie BA, Frey Frøslie K, Thorsby E, Broomé U, Schrumpf E, Boberg KM. Karlsen TH, et al. Among authors: schrumpf e. Gastroenterology. 2006 Sep;131(3):781-7. doi: 10.1053/j.gastro.2006.05.057. Gastroenterology. 2006. PMID: 16952547

8

Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.

Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broomé U, Schreiber S, Boberg KM. Karlsen TH, et al. Among authors: schrumpf e. Am J Gastroenterol. 2007 Jan;102(1):115-21. doi: 10.1111/j.1572-0241.2006.00928.x. Epub 2006 Nov 13. Am J Gastroenterol. 2007. PMID: 17100974

9

Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.

Karlsen TH, Boberg KM, Olsson M, Sun JY, Senitzer D, Bergquist A, Schrumpf E, Thorsby E, Lie BA. Karlsen TH, et al. Among authors: schrumpf e. J Hepatol. 2007 May;46(5):899-906. doi: 10.1016/j.jhep.2007.01.032. Epub 2007 Feb 27. J Hepatol. 2007. PMID: 17383044

10

Gallbladder polyps in primary sclerosing cholangitis: not so benign.

Karlsen TH, Schrumpf E, Boberg KM. Karlsen TH, et al. Among authors: schrumpf e. Curr Opin Gastroenterol. 2008 May;24(3):395-9. doi: 10.1097/MOG.0b013e3282f5727a. Curr Opin Gastroenterol. 2008. PMID: 18408471 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

257 results

Search Page

Filters